Action Csl - CSLCD

Csl Ltd (CSLCD) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

296,65

( - )

Prix Achat

282,00

Prix Vente

304,50

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

296,65

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a...

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

By Chris Wack Arcturus Therapeutics Holdings Inc. shares were up 31% to $24.03 after it entered into a strategic collaboration with CSL Seqirus...

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

By Josh Beckerman Arcturus Therapeutics Holdings Inc. shares rose 26% to $23.10 after hours as the company announced a vaccine collaboration with...

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

By Joshua Kirby Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia's CSL Ltd. that...

Le laboratoire CSL offre 11,7 milliards de dollars pour acquérir le suisse Vifor Pharma

SYDNEY (Agefi-Dow Jones)--Le laboratoire biopharmaceutique australien CSL a annoncé avoir soumis une offre en numéraire de 11,7...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it has made a US$11.7 billion all-cash offer for Switzerland's...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. has made an all-cash offer for Vifor Pharma Ltd. that values the Swiss...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the...

CSL in Talks With Vifor Pharma Over Potential Transaction

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it is in talks with Vifor Pharma Ltd. over a potential acquisition of...

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

By Mike Cherney SYDNEY -- A Covid-19 vaccine candidate in Australia has been scrapped because recipients returned false positives on certain HIV...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

CSLCD - Frequently Asked Questions (FAQ)

What is the current Csl Ltd share price?

The current share price of Csl Ltd is AUD 296,65

What is the 1 year trading range for Csl Ltd share price?

Csl Ltd has traded in the range of AUD 0,00 to AUD 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Csl Ltd (CSLCD)

Csl Ltd (CSLCD) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

CSLCD Dernières nouvelles

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

Le laboratoire CSL offre 11,7 milliards de dollars pour acquérir le suisse Vifor Pharma

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

CSL in Talks With Vifor Pharma Over Potential Transaction

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

CSLCD - Frequently Asked Questions (FAQ)

CSLCD Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Csl Ltd (CSLCD)

Csl Ltd (CSLCD) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

CSLCD Dernières nouvelles

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

Le laboratoire CSL offre 11,7 milliards de dollars pour acquérir le suisse Vifor Pharma

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

CSL in Talks With Vifor Pharma Over Potential Transaction

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

CSLCD - Frequently Asked Questions (FAQ)

CSLCD Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE